Reference is made to the stock exchange notices from Aqua Bio Technology ASA ("ABT" or the "Company") published on 12 February 2026 regarding the successful placement of a private placement of 2,000,000 new shares (the "New Shares") in the Company, at a subscription price of NOK 5.00 per New Share (the "Private Placement"), corresponding to the par value of the shares of the Company following a reverse share split to be implemented prior to formal completion of the Private Placement.
The following primary insiders or close associates of primary insiders have been allocated New Shares:
· Norlane AS, a company closely associated with Chairman Roger Sedal, was allocated 99,720 New Shares, for a total subscription amount of NOK 498,600 to be settled through conversion of debt.
· Terabyte Holding AS, a company closely associated with Board member Terje Blytt, was allocated 138,660 New Shares, for a total subscription amount of NOK 693,300 to be settled through conversion of debt.
· Caprock AS, a company closely associated with CEO and CFO Kristian Flaten, was allocated 60,000 New Shares, for a total subscription amount of NOK 300,000 to be settled in cash.
Please see the attached notification forms for further information.
The issuance of the New Shares will be discussed in an extraordinary general meeting to be held on 16 February 2026. The Company has secured sufficient voting undertakings in order for the share capital increase in connection with the Private Placement to be approved at the extraordinary general meeting.
This information is subject to the disclosure requirements pursuant to MAR article 19.